RHUMBLINE ADVISERS - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 128 filers reported holding ANAPTYSBIO INC in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$542,396
-12.3%
30,201
-0.6%
0.00%0.0%
Q2 2023$618,173
+84813.9%
30,392
-9.2%
0.00%0.0%
Q1 2023$728
-29.1%
33,474
+1.0%
0.00%0.0%
Q4 2022$1,027
-99.9%
33,131
+1.5%
0.00%0.0%
Q3 2022$832,000
+34.0%
32,632
+6.7%
0.00%0.0%
Q2 2022$621,000
-2.4%
30,597
+19.0%
0.00%0.0%
Q1 2022$636,000
-39.7%
25,702
-15.3%
0.00%0.0%
Q4 2021$1,054,000
+26.8%
30,337
-1.0%
0.00%0.0%
Q3 2021$831,000
+6.1%
30,647
+1.5%
0.00%0.0%
Q2 2021$783,000
-1.6%
30,187
-18.3%
0.00%0.0%
Q1 2021$796,000
-5.4%
36,939
-5.6%
0.00%0.0%
Q4 2020$841,000
+59.0%
39,124
+9.2%
0.00%0.0%
Q3 2020$529,000
-43.2%
35,837
-14.0%
0.00%
-50.0%
Q2 2020$931,000
+94.4%
41,656
+22.8%
0.00%
+100.0%
Q1 2020$479,000
-11.5%
33,925
+1.9%
0.00%0.0%
Q4 2019$541,000
-53.2%
33,303
+0.9%
0.00%
-50.0%
Q3 2019$1,155,000
-37.3%
33,015
+1.1%
0.00%
-33.3%
Q2 2019$1,843,000
-10.0%
32,664
+16.5%
0.00%
-25.0%
Q1 2019$2,048,000
+13.9%
28,041
-0.5%
0.00%0.0%
Q4 2018$1,798,000
+4.9%
28,181
+64.0%
0.00%
+33.3%
Q3 2018$1,714,000
+32.3%
17,180
-5.8%
0.00%0.0%
Q2 2018$1,296,000
-27.0%
18,242
+6.9%
0.00%
-25.0%
Q1 2018$1,776,000
+9.8%
17,062
+6.2%
0.00%
+33.3%
Q4 2017$1,618,000
+342.1%
16,063
+53.3%
0.00%
+200.0%
Q3 2017$366,00010,4800.00%
Other shareholders
ANAPTYSBIO INC shareholders Q2 2019
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,688,448$371,500,00060.25%
Cormorant Asset Management, LP 1,251,485$126,050,00013.20%
BVF INC/IL 594,397$59,868,0007.22%
VHCP Management II, LLC 282,550$28,458,0006.82%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 812,484$81,833,0003.22%
Iguana Healthcare Management, LLC 40,000$4,029,0002.62%
Perceptive Advisors 756,387$76,183,0002.52%
Cormorant Asset Management, LP 135,000$13,597,0001.42%
EAM Global Investors LLC 21,734$2,189,0001.12%
PFM Health Sciences, LP 425,896$42,896,0001.02%
View complete list of ANAPTYSBIO INC shareholders